Role of neuropeptides and neuroamino acids in central regulation of blood pressure
神经肽和神经氨基酸在血压中枢调节中的作用
基本信息
- 批准号:59480123
- 负责人:
- 金额:$ 4.1万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1984
- 资助国家:日本
- 起止时间:1984 至 1986
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1) In Wistar rats, angiotensin <II> (A <II> ) injected into the posterior hypothalamus and renin administered to the cerebroventricle (CV) induces pressor and positive chronotropic responses. A <II> injected to the preoptic area (POA) stimulate water intake, but not salt intake, and renin injected to the same area both water and salt intakes. 2) Taurine and <gamma> -aminobutyric acid (GABA) i.c.v. do not elicit fluid intakes, but show depressor and negative chronotropic responses. 3) These two amino acids can antagonize central effects of renin and A <II> on cardiovascular system and fluid intakes. However, these acids do not affect pressor responses to centrally administered prostaglandin <F_(2(alpha))> , carbachol and histamine. Among amino acids, cystein, methionine, cystein sulfinic acid and alanine are lack of showing such antagonism. Thus taurine and GABA seem to be selectively antagonize for A <II> and renin. 4) Stimulation of fluid intakes produced by POA injection of A <II> or … More renin is inhibited by GABA and taurine administered to CV as well as POA at 1/10 smaller dose. However pressor responses to POA injected A <II> is inhibited by CV administration of these acids, but not by POA administration. A <II> administered to the suprachiasmatic nucleus bring about moderate rise of blood pressure, but, when administered to paraventricular nucleus and central amygdaloid nucleus, it do not exert act on blood pressure. Thus, POA seems to be one of site of antagonism for fluid intake, but not for blood pressure. 5) In spontaneously hypertensive rats (SHR), pressor responses to A <II> and renin injected to CV or POA are potentiated as compared with those in control Wistar-Kyoto rats. Salt intake, but not water intake, produced by POA injection of A <II> or renin is also exaggerated in SHR. On the contrary, depressor response to taurine administered into CV is reduced in SHR. These central effects of A <II> and renin in SHR and Wistar Kyoto rats are inhibited by central administration of taurine or GABA. 6) When 3% taurine-contained water is given to SHR from 4- to 15 weeks after birth, such exaggerated central effects of A <II> and renin on blood pressure and salt appetite are markedly reduced, in addition to inhibition of development of hypertension. 7) In conclusion, renin and angiotensin seem to be centrally involved in development and maintenance of hypertension and these effects are antagonized taurine and GABA, neuroamino acids. Less
1) Wistar大鼠下丘脑后部注射血管紧张素<II> (A <II>)和脑室肾素(CV)可诱导升压反应和正向变时反应。A <II>注入视前区(POA)刺激水的摄入,但不刺激盐的摄入,肾素注入同一区域既刺激水又刺激盐的摄入。2)牛磺酸和< γ > -氨基丁酸(GABA)不引起液体摄入,但表现出抑制和负性变时反应。3)这两种氨基酸可拮抗肾素和A <II>对心血管系统和液体摄入的中枢作用。然而,这些酸不影响中央给药前列腺素<F_(2(α))>、氨基酚和组胺的降压反应。氨基酸中,半胱氨酸、蛋氨酸、半胱氨酸、亚磺酸和丙氨酸缺乏这种拮抗作用。因此,牛磺酸和GABA似乎对A <II>和肾素具有选择性拮抗作用。1/10剂量的谷丙磺酸和氨基丁酸能抑制更多的肾素。然而,注射A <II>的POA的加压反应被这些酸的CV给药抑制,而POA给药不被抑制。给药于视交叉上核可使血压中度升高,但给药于室旁核和中央杏仁核对血压无作用。因此,POA似乎是液体摄入的拮抗部位之一,而不是血压的拮抗部位。5)在自发性高血压大鼠(SHR)中,与Wistar-Kyoto对照大鼠相比,A <II>和肾素注射对CV或POA的升压反应增强。在SHR中,注射A <II>或肾素的POA产生的盐摄入量,而不是水摄入量也被夸大。相反,在SHR中,牛磺酸对CV的抑制反应降低。在SHR和Wistar Kyoto大鼠中,A <II>和肾素的这些中枢作用被牛磺酸或GABA的中枢作用所抑制。6)出生后4 ~ 15周给予SHR 3%牛磺酸水,除了抑制高血压的发展外,A <II>和肾素对血压和盐食欲的夸大中枢作用显著降低。7)总之,肾素和血管紧张素似乎在高血压的发生和维持中起主要作用,这些作用是由牛磺酸和GABA等神经氨基酸拮抗的。少
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tatsuo Furukawa, et al.: "Inhibition by oral taurine of blood pressure and renin-induced salt intake in spontaneously hypertensive rats" Jap. J. Pharmacol.43(Suppl.). 267p (1987)
Tatsuo Furukawa 等人:“口服牛磺酸对自发性高血压大鼠的血压和肾素诱导的盐摄入量的抑制”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tatsuo Furukawa, et al.: "Effects of neuropeptides and neuroamino acids on water intakes centrally evoked" Nichiyakurishi (in Japanese). 86(4). 39p (1986)
Tatsuo Furukawa 等人:“神经肽和神经氨基酸对集中诱发的水摄入量的影响”Nichiyakurishi(日语)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tatsuo Furukawa,et al.: Jap.J.Pharmacol.43 Suppl.71P (1987)
Tatsuo Furukawa 等人:Jap.J.Pharmacol.43 Suppl.71P (1987)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tatsuo Furukawa,et al.: Neuropharmacology. (1987)
Tatsuo Furukawa 等人:神经药理学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tatsuo Furukawa: "Regulation of blood pressure and sulfur amino acids" Sulfur Amino Acids (in Japanese). 9. 1-12 (1986)
Tatsuo Furukawa:“血压和硫氨基酸的调节”硫氨基酸(日语)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FURUKAWA Tatsuo其他文献
FURUKAWA Tatsuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FURUKAWA Tatsuo', 18)}}的其他基金
Analysis of the novel gene identified using a SEREX method in the senrm of bone marrow failure patients
骨髓衰竭患者血清中SEREX方法鉴定的新基因分析
- 批准号:
18591048 - 财政年份:2006
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of novel leukemia associated antigen which may useful for immunotherapy of leukemia patients
新型白血病相关抗原的鉴定可用于白血病患者的免疫治疗
- 批准号:
15590997 - 财政年份:2003
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The effects of hematopoietic cytokines, and the changes of transcriptional factors during the proliferation, differentiation, and maturation of basophilic and eosinophilic progenitors
嗜碱性和嗜酸性祖细胞增殖、分化和成熟过程中造血细胞因子的作用和转录因子的变化
- 批准号:
09671102 - 财政年份:1997
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Involvement of neuropeptides and amino acids in central regulation of blood pressure.
神经肽和氨基酸参与血压的中枢调节。
- 批准号:
63480121 - 财政年份:1988
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
内源性Angiotensin Ⅱ通过脊髓背角星形胶质细胞谷氨酸转运体-1 (GLT-1)调控糖尿病神经病理性痛的机制研究
- 批准号:81871088
- 批准年份:2018
- 资助金额:56.0 万元
- 项目类别:面上项目
Renin-Angiotensin System在介导机械通气所致肺微血管内皮细胞功能障碍中的作用及其机制研究
- 批准号:81372100
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
相似海外基金
The Renin-Angiotensin System in Air Pollution-Mediated Exacerbation of Obesity.
空气污染介导的肥胖加剧中的肾素-血管紧张素系统。
- 批准号:
10654124 - 财政年份:2023
- 资助金额:
$ 4.1万 - 项目类别:
ROLE OF ANGIOTENSIN-(1-7) AND DIAPHRAGM VASCULAR FUNCTION IN HEART FAILURE AND PROLONGED MECHANICAL VENTILATION
血管紧张素-(1-7) 和隔膜血管功能在心力衰竭和长时间机械通气中的作用
- 批准号:
10607545 - 财政年份:2023
- 资助金额:
$ 4.1万 - 项目类别:
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 4.1万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 4.1万 - 项目类别:
Addressing the Racial Disparity of Angiotensin Inhibitor Benefit in HFrEF Hospitalizations: Distinguishing Genomic and Social Factors
解决 HFrEF 住院期间血管紧张素抑制剂获益的种族差异:区分基因组和社会因素
- 批准号:
10605868 - 财政年份:2023
- 资助金额:
$ 4.1万 - 项目类别:
Angiotensin-(1-7) engages hypothalamic arcuate-paraventricular nucleus inhibitory pathways to lower blood pressure
血管紧张素-(1-7) 参与下丘脑弓状室旁核抑制通路来降低血压
- 批准号:
10751682 - 财政年份:2023
- 资助金额:
$ 4.1万 - 项目类别:
Skin tissue renin-angiotensin system as a novel mechanism of hypertension
皮肤组织肾素-血管紧张素系统作为高血压的新机制
- 批准号:
23K07678 - 财政年份:2023
- 资助金额:
$ 4.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of the renin angiotensin system on MRI volumetric measures and cognitive function in the Alzheimer's disease process: the LookAHEAD study
肾素血管紧张素系统对阿尔茨海默病过程中 MRI 体积测量和认知功能的影响:LookAHEAD 研究
- 批准号:
10447980 - 财政年份:2022
- 资助金额:
$ 4.1万 - 项目类别:
Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood Pressure
利钠肽-肾素-血管紧张素-醛固酮系统节律轴与夜间血压
- 批准号:
10545747 - 财政年份:2022
- 资助金额:
$ 4.1万 - 项目类别:
Effects of the renin angiotensin system on MRI volumetric measures and cognitive function in the Alzheimer's disease process: the LookAHEAD study
肾素血管紧张素系统对阿尔茨海默病过程中 MRI 体积测量和认知功能的影响:LookAHEAD 研究
- 批准号:
10645040 - 财政年份:2022
- 资助金额:
$ 4.1万 - 项目类别: